Filing Details
- Accession Number:
- 0001127602-21-003799
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-03 18:05:44
- Reporting Period:
- 2021-02-01
- Accepted Time:
- 2021-02-03 18:05:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1703647 | Frequency Therapeutics Inc. | FREQ | Pharmaceutical Preparations (2834) | 472324450 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1785288 | L. David Lucchino | C/O Frequency Therapeutics, Inc. 19 Presidential Way, 2Nd Floor Woburn MA 01801 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-02-01 | 33,102 | $0.61 | 341,188 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-01 | 2,900 | $41.29 | 338,288 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-01 | 18,600 | $42.85 | 319,688 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-01 | 8,900 | $43.71 | 310,788 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-01 | 2,702 | $44.58 | 308,086 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2021-02-01 | 33,102 | $0.00 | 33,102 | $0.61 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 204,549 | 2028-05-21 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2020.
- This transaction was executed in multiple trades through a broker-dealer at prices ranging from $40.87 to $41.695. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- This transaction was executed in multiple trades through a broker-dealer at prices ranging from $42.2950 to $43.2800. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- This transaction was executed in multiple trades through a broker-dealer at prices ranging from $43.3100 to $44.2400. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- This transaction was executed in multiple trades through a broker-dealer at prices ranging from $44.4400 to $44.7250. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- The option vests and becomes exercisable in equal monthly installments over a four year period commencing on February 1, 2018, and will be fully vested and exercisable on January 1, 2022.
Billionaire Hedge Funds
